Your browser doesn't support javascript.
loading
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients.
Weinhold, Niels; Salwender, Hans J; Cairns, David A; Raab, Marc S; Waldron, George; Blau, Igor W; Bertsch, Uta; Hielscher, Thomas; Morgan, Gareth J; Jauch, Anna; Davies, Faith E; Hänel, Mathias; Cook, Gordon; Scheid, Christoph; Houlston, Richard; Goldschmidt, Hartmut; Jackson, Graham; Kaiser, Martin F.
Afiliación
  • Weinhold N; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg. Niels.Weinhold@med.uni-heidelberg.de.
  • Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg.
  • Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, Leeds.
  • Raab MS; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg.
  • Waldron G; Division of Genetics and Epidemiology, The Institute of Cancer Research, London.
  • Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin.
  • Bertsch U; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg.
  • Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg.
  • Morgan GJ; Perlmutter Cancer Center, NYU Langone Health, New York.
  • Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg.
  • Davies FE; Perlmutter Cancer Center, NYU Langone Health, New York.
  • Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz.
  • Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds.
  • Scheid C; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne.
  • Houlston R; Division of Genetics and Epidemiology, The Institute of Cancer Research, London.
  • Goldschmidt H; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases (NCT), University Clinic Heidelberg, Heidelberg.
  • Jackson G; Department of Haematology, University of Newcastle, Newcastle Upon Tyne.
  • Kaiser MF; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom; Department of Haematology, The Royal Marsden Hospital, London. martin.kaiser@icr.ac.uk.
Haematologica ; 106(10): 2754-2758, 2021 10 01.
Article en En | MEDLINE | ID: mdl-34092058
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article